サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1479991

エクソソーム研究の世界市場の評価：製品・サービス別、適応症タイプ別、用途タイプ別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Exosome Research Market Assessment, By Product and Service, By Indication Type, By Application Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日
ページ情報
英文 222 Pages
納期
3～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
エクソソーム研究の世界市場の評価：製品・サービス別、適応症タイプ別、用途タイプ別、エンドユーザー別、地域別、機会、予測（2017年～2031年）
出版日: 2024年05月17日
発行: Market Xcel - Markets and Data
ページ情報: 英文 222 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のエクソソーム研究の市場規模は、2023年の2億344万米ドルから2031年に7億3,264万米ドルに達すると予測され、予測期間の2024年～2031年にCAGRで17.37％の成長が見込まれます。市場は近年著しい成長を示しており、今後も堅調な拡大ペースを維持すると予測されます。

エクソソームは細胞から放出される微小な細胞外小胞であり、細胞間コミュニケーションにおいて重要な役割を果たしています。これらの小胞は、タンパク質、脂質、核酸などのさまざまな生体分子で構成されており、診断や治療の目的で使用することができます。市場には、エクソソームの分析、精製、単離に使用される検出キット、単離キット、特性評価キットなどのさまざまな製品が含まれます。これらのエクソソームは、疾患の診断やモニタリングに用いるバイオマーカーとして、また標的治療におけるドラッグデリバリーに使用することができます。

世界のエクソソーム研究市場は、研究開発への支出の増加、慢性疾患の有病率の上昇、老年人口の増加、医療部門全体の技術拡大により、急成長が見込まれています。医療提供者と業界の大手企業は、患者に最善の診断アプローチを提供するために協力しています。資金が調達され、政府機関と非公開会社の両方から多額の投資が行われています。こうした巨大企業が新製品を発売したり開発したりする際には、M&Aや投資、パートナーシップといった戦略的な取り組みが登場します。2022年8月、Creative Biolabsは、エクソソームの特性解析に使用されるNanosightプラットフォームと呼ばれる先進のプラットフォームを発表しました。このプラットフォームは、あらゆる研究機関や産業顧客がサイズ分布分析、エクソソーム濃度測定、表現型評価などに利用できます。

研究開発費の増加

世界のエクソソーム研究市場は、研究投資の増加により大きく成長しています。このような資金援助により、科学者たちは現在、エクソソームをより詳細に、より深く研究することができるようになり、その結果、知識と治療への応用が向上しています。エクソソームの単離、分析、特性解析に向けた新しい技術や手法の開発は、エクソソーム研究への資金提供の増加によって可能となっています。その結果、エクソソーム研究市場では、さまざまな疾患の診断や治療におけるエクソソームの新用途だけでなく、新しい商品やサービスの開発が見られるようになっています。エクソソーム研究市場が成長したのは、このように幅広い研究に焦点が当てられ、エクソソームの臨床用途に関する知識も向上したからです。エクソソームに基づく治療法は近年、複数の企業のパイプラインに組み込まれています。エクソソーム研究市場が注力している主な分野の1つは、エクソソームの新規分離技術と強化技術の開発です。高スループットのエクソソーム抽出に向けたマイクロ流体デバイスの使用や、特定の細胞タイプからエクソソームを分離する新技術の開発は、この分野における近年の発展の一例です。

例えば、プレシジョンオンコロジーを専門とするGuardant Healthは、2022年にGuardant360検査と呼ばれる検査を開発しました。この検査は、血流中のエクソソームから抽出される血中循環腫瘍DNA（ctDNA）を利用し、がんに関連する変異を検出するものです。このリキッドバイオプシー検査は、従来の組織生検に代わる非侵襲的な検査で、簡単な採血でさまざまな種類のがんを検出およびモニタリングできます。

慢性疾患の有病率の増加

世界のエクソソーム研究市場は、慢性疾患の罹患率の上昇によって大きな影響を受けています。世界中で何百万人もの人々ががん、心臓病、神経疾患などの慢性疾患の影響を受けており、公衆衛生に深刻な課題をもたらしています。エクソソーム研究市場は、さまざまな種類の慢性疾患を治療する治療・診断ツールとしてのエクソソームの将来性の結果として拡大しています。研究は現在、慢性疾患の有病率の上昇によってより注目されており、エクソソームが疾患のモニタリング、診断、治療において重要な役割を果たす機会をもたらしています。

当レポートでは、世界のエクソソーム研究市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界のエクソソーム研究市場の見通し（2017年～2031年）

  • 市場規模と予測
    • 金額
    • 数量
  • 製品・サービス別
    • キット、試薬
    • 器具
    • サービス
  • 適応症タイプ別
    • がん
    • 神経変性疾患
    • 心血管疾患
    • 感染症
    • その他
  • 用途タイプ別
    • バイオマーカー
    • ワクチン開発
    • 組織再生
    • その他
  • エンドユーザー別
    • 製薬、バイオテクノロジー企業
    • 病院、臨床検査室
    • 学術、研究機関
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 南米
    • 中東・アフリカ
  • 市場シェア：企業別（2023年）

第5章 世界のエクソソーム研究市場の見通し：地域別（2017年～2031年）

  • 北米
    • 市場規模と予測
    • 製品・サービス別
    • 適応症タイプ別
    • 用途タイプ別
    • エンドユーザー別
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • 英国
    • ロシア
    • オランダ
    • スペイン
    • トルコ
    • ポーランド
  • アジア太平洋
    • インド
    • 中国
    • 日本
    • オーストラリア
    • ベトナム
    • 韓国
    • インドネシア
    • フィリピン
  • 南米
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ

第6章 市場マッピング（2023年）

  • 製品・サービス別
  • 適応症タイプ別
  • 用途タイプ別
  • エンドユーザー別
  • 地域別

第7章 マクロ環境と産業構造

  • 需給分析
  • 輸入輸出分析
  • バリューチェーン分析
  • PESTEL分析
  • ポーターのファイブフォース分析

第8章 市場力学

  • 成長促進要因
  • 成長抑制要因（課題、抑制要因）

第9章 規制枠組みとイノベーション

  • 臨床試験
  • 規制当局の承認
  • イノベーション/新技術

第10章 主要企業の情勢

  • マーケットリーダー上位5社の競合マトリクス
  • マーケットリーダー上位5社の市場収益分析（2023年）
  • 合併と買収/合弁事業（該当する場合）
  • SWOT分析（市場企業5社）

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

  • Thermo Fisher Scientific, Inc
  • Products and Services
  • Qiagen
  • Lonza Group Ltd
  • System Biosciences, LLC
  • Bio-Techne Corporation
  • Danaher Corporation
  • Amsbio Holdings Limited
  • RoosterBio, Inc.
  • Miltenyi Biotec India Private Limited
  • Norgen Biotek Corp.

第14章 戦略的推奨

第15章 当社について、免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 2.Global Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 3.Global Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 4.Global Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 5.Global Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 6.Global Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 7.Global Exosome Research Market Share (%), By Region, 2017-2031F
  • Figure 8.North America Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 9.North America Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 10.North America Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 11.North America Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 12.North America Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 13.North America Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 14.North America Exosome Research Market Share (%), By Country, 2017-2031F
  • Figure 15.United States Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 16.United States Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 17.United States Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 18.United States Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 19.United States Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 20.United States Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 21.Canada Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 22.Canada Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 23.Canada Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 24.Canada Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 25.Canada Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 26.Canada Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 27.Mexico Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 28.Mexico Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 29.Mexico Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 30.Mexico Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 31.Mexico Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 32.Mexico Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 33.Europe Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 34.Europe Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 35.Europe Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 36.Europe Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 37.Europe Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 38.Europe Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 39.Europe Exosome Research Market Share (%), By Country, 2017-2031F
  • Figure 40.Germany Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 41.Germany Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 42.Germany Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 43.Germany Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 44.Germany Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 45.Germany Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 46.France Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 47.France Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 48.France Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 49.France Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 50.France Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 51.France Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 52.Italy Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 53.Italy Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 54.Italy Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 55.Italy Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 56.Italy Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 57.Italy Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 58.United Kingdom Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 59.United Kingdom Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 60.United Kingdom Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 61.United Kingdom Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 62.United Kingdom Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 63.United Kingdom Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 64.Russia Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 65.Russia Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 66.Russia Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 67.Russia Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 68.Russia Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 69.Russia Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 70.Netherlands Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 71.Netherlands Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 72.Netherlands Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 73.Netherlands Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 74.Netherlands Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 75.Netherlands Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 76.Spain Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 77.Spain Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 78.Spain Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 79.Spain Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 80.Spain Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 81.Spain Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 82.Turkey Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 83.Turkey Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 84.Turkey Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 85.Turkey Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 86.Turkey Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 87.Turkey Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 88.Poland Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 89.Poland Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 90.Poland Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 91.Poland Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 92.Poland Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 93.Poland Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 94.South America Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 95.South America Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 96.South America Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 97.South America Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 98.South America Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 99.South America Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 100.South America Exosome Research Market Share (%), By Country, 2017-2031F
  • Figure 101.Brazil Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 102.Brazil Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 103.Brazil Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 104.Brazil Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 105.Brazil Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 106.Brazil Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 107.Argentina Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 108.Argentina Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 109.Argentina Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 110.Argentina Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 111.Argentina Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 112.Argentina Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 113.Asia-Pacific Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 114.Asia-Pacific Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 115.Asia-Pacific Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 116.Asia-Pacific Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 117.Asia-Pacific Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 118.Asia-Pacific Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 119.Asia-Pacific Exosome Research Market Share (%), By Country, 2017-2031F
  • Figure 120.India Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 121.India Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 122.India Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 123.India Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 124.India Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 125.India Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 126.China Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 127.China Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 128.China Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 129.China Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 130.China Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 131.China Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 132.Japan Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 133.Japan Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 134.Japan Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 135.Japan Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 136.Japan Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 137.Japan Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 138.Australia Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 139.Australia Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 140.Australia Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 141.Australia Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 142.Australia Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 143.Australia Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 144.Vietnam Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 145.Vietnam Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 146.Vietnam Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 147.Vietnam Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 148.Vietnam Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 149.Vietnam Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 150.South Korea Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 151.South Korea Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 152.South Korea Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 153.South Korea Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 154.South Korea Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 155.South Korea Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 156.Indonesia Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 157.Indonesia Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 158.Indonesia Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 159.Indonesia Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 160.Indonesia Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 161.Indonesia Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 162.Philippines Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 163.Philippines Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 164.Philippines Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 165.Philippines Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 166.Philippines Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 167.Philippines Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 168.Middle East & Africa Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 169.Middle East & Africa Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 170.Middle East & Africa Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 171.Middle East & Africa Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 172.Middle East & Africa Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 173.Middle East & Africa Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 174.Middle East & Africa Exosome Research Market Share (%), By Country, 2017-2031F
  • Figure 175.Saudi Arabia Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 176.Saudi Arabia Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 177.Saudi Arabia Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 178.Saudi Arabia Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 179.Saudi Arabia Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 180.Saudi Arabia Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 181.UAE Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 182.UAE Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 183.UAE Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 184.UAE Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 185.UAE Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 186.UAE Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 187.South Africa Exosome Research Market, By Value, In USD Million, 2017-2031F
  • Figure 188.South Africa Exosome Research Market, By Volume, In Million Units, 2017-2031F
  • Figure 189.South Africa Exosome Research Market Share (%), By Product and Service, 2017-2031F
  • Figure 190.South Africa Exosome Research Market Share (%), By Indication Type, 2017-2031F
  • Figure 191.South Africa Exosome Research Market Share (%), By Application Type, 2017-2031F
  • Figure 192.South Africa Exosome Research Market Share (%), By End-user, 2017-2031F
  • Figure 193.By Product and Service Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 194.By Indication Type Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 195.By Application Type Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 196.By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 197.By Region Map-Market Size (USD Million) & Growth Rate (%), 2023
目次
Product Code: MX11336

Global exosome research market is projected to witness a CAGR of 17.37% during the forecast period 2024-2031, growing from USD 203.44 million in 2023 to USD 732.64 million in 2031. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years.

Exosomes are tiny extracellular vesicles released by cells and play an important role in intercellular communication. These vesicles consist of different biomolecules such as proteins, lipids, and nucleic acids, which can be used for diagnostic and therapeutic purposes. Its market includes various products such as detection kits, isolation kits, and characterization kits used for the analysis, purification, and isolation of exosomes. These exosomes can be used as biomarkers to diagnose diseases and monitor them, as well as for drug delivery in targeted therapies.

The global exosome research market is expected to grow rapidly due to increasing expenditure on research and development, rising prevalence of chronic diseases, rising geriatric population, and expanding technology throughout the healthcare sector. Healthcare providers and industry giants are coming together to bring out their best diagnostic approaches for patients. Funds are being raised, and a hefty amount is being invested by both government bodies and private companies. Strategic initiatives such as mergers and acquisitions, investments, and partnerships come into play when these huge companies are trying to launch or develop a new product. In August 2022, Creative Biolabs launched an advanced platform called the Nanosight platform, which is used for exosome characterization. This platform is accessible to all kinds of research and industrial customers for size distribution analysis, exosome concentration measurement, and phenotypic evaluation.

Increasing Expenditure on Research and Development

The global market for exosome research has grown significantly due to increasing research investments. With the help of this funding, scientists have now been able to study exosomes in greater detail and with greater depth, which has improved their knowledge and therapeutic applications. The development of novel technologies and methods for the isolation, analysis, and characterization of exosomes has been made possible by increased funding for exosome research. As a result, the market for exosome research has seen the development of new goods and services as well as novel uses for exosomes in the diagnosis and treatment of various diseases. The exosome research market has grown because of this broader research focus, which has also improved knowledge of the clinical uses of exosomes. Exosome-based treatments have lately been included in the pipelines of several businesses. One of the main areas of concentration for the exosome research market has been the creation of novel and enhanced exosome isolation technologies. The use of microfluidic devices for high-throughput exosome extraction and the creation of novel techniques for separating exosomes from particular cell types are examples of recent developments in this field.

For instance, Guardant Health, which specializes in precision oncology, developed a test called the Guardant360 test in 2022 that utilizes circulating tumor DNA (ctDNA), which is extracted from exosomes in the bloodstream and used to detect cancer-related mutations. This liquid biopsy test offers a non-invasive alternative to traditional tissue biopsies, allowing for the detection and monitoring of various cancer types through a simple blood draw.

Increasing Prevalence of Chronic Diseases

The global market for exosome research is being significantly impacted by the rising incidence of chronic illnesses. Millions of individuals worldwide are impacted by chronic diseases like cancer, heart disease, and neurological problems, which pose serious challenges to public health. The exosome research market is expanding as a result of exosomes' potential as therapeutic and diagnostic tools to treat different types of chronic diseases. Research is now receiving more attention due to the rise in prevalence of chronic illnesses, which presents a chance for exosomes to play a crucial role in disease monitoring, diagnosis, and therapy.

The industry is expanding because researchers are looking at exosomes' potential as medicines and biomarkers. Exosomes have shown promising results as a unique class of treatments that can transport medications and genetic material to certain cells and tissues. Exosome-based therapies and products have been developed in response to the growing need for innovative treatments brought on by the increased prevalence of chronic diseases.

Exosomes found in biological fluids can be analyzed to find biomarkers that might point to the existence of a disease. This has fueled the development of fresh exosome-based diagnostic instruments and assays, which has increased demand for exosome research. There is a huge market demand for innovative and efficient treatments as well as diagnostic instruments due to the rising incidence of chronic illnesses.

Exosome research has increased in response to demand, as exosomes have shown promise as a potential remedy for various ailments. A report published by NIH in January 2023 stated that in the US, the number of people who are above the age of 50 will increase from 137.25 million in 2020 to 221.13 million in 2050, a significant increase of 61.11%. The number of people 50 years of age and older who have at least one chronic illness is predicted to increase from 71.522 million in 2020 to 142.66 million in 2050.

Growth In Various Therapeutic Applications of Exosomes

Exosomes may be employed as a platform for therapeutic intervention for various diseases. Exosomes can be used in clinical settings as cell-free substitutes to treat a variety of illnesses and promote tissue regeneration since they can carry therapeutic cargo components without causing cellular toxicity or immunological rejection. Exosomes produced from stem cells have the benefit of using the regenerative and anti-inflammatory properties of their parent cells; as a result, respiratory virus infections can be treated with exosomal therapy. Given their natural material transportation qualities, capacity to sustain intrinsic long-term circulation, and high biocompatibility - all of which make them ideal for the delivery of a wide range of proteins, chemicals, and nucleic acids - exosomes make great drug delivery vehicles.

Exosomes have proved to be promising as intercellular communication mediators, potentially transporting functional proteins, mRNA transcripts, and miRNAs to cells all over the body, according to a few research investigations. Exosomes are biocompatible and are effective agents in a variety of conditions, including organ injuries and ailments of the heart, kidney, liver, and lungs. They are derived from specific cell types, such as mesenchymal and dendritic stem cells. Even though research on exosome uses has advanced at a fast pace, there are still several obstacles in the way of creating treatments based on exosomes, especially when it comes to producing exosome formulations because of their poor productivity and heterogeneity. But finding a way to combat this and be able to fully use their potential in a variety of ways is promising for the expansion of the exosome research market.

In April 2024, Exo Biologics, a clinical-stage biotech company, announced that it has successfully secured a total of EUR 16 million in Series A funding for the development of exosome-based therapies. These funds will be used by them to support its future and ongoing trials. It will also continue its manufacturing expansion, including upgrading its unique production platform, ExoPulse (TM), and expanding partnerships to enable pan-market access to the platform and GMP clinical grade exosomes for faster access to clinical trials.

North America Dominates the Exosome Research Market

North America accounts for the highest market shares of exosomes due to its advanced healthcare system, favorable laws, an extensive network of multinational corporations, and high level of knowledge among people about healthcare and diagnostics. Numerous government-funded studies have been carried out in the region to investigate the potential involvement of medications utilizing exosomes in various cancer types, including pancreatic cancer, melanoma, lung cancer, and breast cancer. Universities like Yale University and Michigan State University have partnered with and are being supported by companies like Merck and Exosome Diagnostic to carry out clinical trials in the US. Moreover, government funding for these endeavors is excellent. The United States is witnessing widespread use of cutting-edge micro-nanotechnologies for extracellular vesicles in immuno-oncology, spanning from immunomodulation to target-specific isolations. In the upcoming years, the market under study is anticipated to increase rapidly due to the implementation of new technologies.

Future Market Scenario (2024-2031F)

The market growth of exosome research is steadily increasing due to several factors. This market is expected to consistently grow in the future because of how promising its uses can be in developing diagnostics and therapeutics. As the geriatric population increases, so will the number of patients. People are widely accepting new diagnostic methods and developments to combat their illnesses. For example, according to the Lab Chip Journal, in July 2022, the United States experienced a wide adoption of emerging micro-nanotechnologies for extracellular vesicles in immuno-oncology, ranging from target-specific isolations to immunomodulation.

Key Players Landscape and Outlook

Several companies such as Thermo Fisher Scientific, Inc, Qiagen, Lonza Group Ltd, System Biosciences, LLC, Bio-Techne Corporation, Danaher Corporation, Amsbio Holdings Limited, RoosterBio, Inc., Miltenyi Biotec India Private Limited, Norgen Biotek Corp., etc. are expanding their businesses by planning and adopting new strategies. They are adopting new strategic initiatives regarding exosome research to help researchers and increase their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments, and partnerships are a few ways through which they are trying to achieve the same.

In July 2022, Cells for Cells, a clinical-stage biotech pioneering allogeneic stem cell and stem-cell-derived therapeutics for high-impact chronic diseases, announced a 6-month follow-up of the groundbreaking clinical data from the first-ever patient dosed with an exosome-produced therapy for osteoarthritis.

In April 2022, Global Stem Cells Group (GSCG) announced the launch of its new product with new lyophilized exosome technology. Global Stem Cells Group's new product line includes innovative anti-aging products that can regenerate cells and tissues in the body.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Exosome Research Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
    • 4.1.2.By Volume
  • 4.2.By Product and Service
    • 4.2.1.Kits and Reagents
    • 4.2.2.Instruments
    • 4.2.3.Services
  • 4.3.By Indication Type
    • 4.3.1.Cancer
    • 4.3.2.Neurodegenerative Diseases
    • 4.3.3.Cardiovascular Diseases
    • 4.3.4.Infectious Diseases
    • 4.3.5.Others
  • 4.4.By Application Type
    • 4.4.1.Biomarkers
    • 4.4.2.Vaccine Development
    • 4.4.3.Tissue Regeneration
    • 4.4.4.Others
  • 4.5.By End-user
    • 4.5.1.Pharmaceutical and Biotechnological Companies
    • 4.5.2.Hospitals and Clinical Testing Laboratories
    • 4.5.3.Academic and Research Institutes
  • 4.6.By Region
    • 4.6.1.North America
    • 4.6.2.Europe
    • 4.6.3.Asia-Pacific
    • 4.6.4.South America
    • 4.6.5.Middle East and Africa
  • 4.7.By Company Market Share (%), 2023

5.Global Exosome Research Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
      • 5.1.1.2.By Volume
    • 5.1.2.By Product and Service
      • 5.1.2.1.Kits and Reagents
      • 5.1.2.2.Instruments
      • 5.1.2.3.Services
    • 5.1.3.By Indication Type
      • 5.1.3.1.Cancer
      • 5.1.3.2.Neurodegenerative Diseases
      • 5.1.3.3.Cardiovascular Diseases
      • 5.1.3.4.Infectious Diseases
      • 5.1.3.5.Others
    • 5.1.4.By Application Type
      • 5.1.4.1.Biomarkers
      • 5.1.4.2.Vaccine Development
      • 5.1.4.3.Tissue Regeneration
      • 5.1.4.4.Others
    • 5.1.5.By End-user
      • 5.1.5.1.Pharmaceutical and Biotechnological Companies
      • 5.1.5.2.Hospitals and Clinical Testing Laboratories
      • 5.1.5.3.Academic and Research Institutes
    • 5.1.6.United States*
      • 5.1.6.1.Market Size & Forecast
        • 5.1.6.1.1.By Value
        • 5.1.6.1.2.By Volume
      • 5.1.6.2.By Product and Service
        • 5.1.6.2.1.Kits and Reagents
        • 5.1.6.2.2.Instruments
        • 5.1.6.2.3.Services
      • 5.1.6.3.By Indication Type
        • 5.1.6.3.1.Cancer
        • 5.1.6.3.2.Neurodegenerative Diseases
        • 5.1.6.3.3.Cardiovascular Diseases
        • 5.1.6.3.4.Infectious Diseases
        • 5.1.6.3.5.Others
      • 5.1.6.4.By Application Type
        • 5.1.6.4.1.Biomarkers
        • 5.1.6.4.2.Vaccine Development
        • 5.1.6.4.3.Tissue Regeneration
        • 5.1.6.4.4.Others
      • 5.1.6.5.By End-user
        • 5.1.6.5.1.Pharmaceutical and Biotechnological Companies
        • 5.1.6.5.2.Hospitals and Clinical Testing Laboratories
        • 5.1.6.5.3.Academic and Research Institutes
    • 5.1.7.Canada
    • 5.1.8.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East and Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Product and Service
  • 6.2.By Indication Type
  • 6.3.By Application Type
  • 6.4.By End-user
  • 6.5.By Region

7.Macro Environment and Industry Structure

  • 7.1.Demand Supply Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat From New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Clinical Trials
  • 9.2.Regulatory Approvals
  • 9.3.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.Thermo Fisher Scientific, Inc
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products and Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus and Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.Qiagen
  • 13.3.Lonza Group Ltd
  • 13.4.System Biosciences, LLC
  • 13.5.Bio-Techne Corporation
  • 13.6.Danaher Corporation
  • 13.7.Amsbio Holdings Limited
  • 13.8.RoosterBio, Inc.
  • 13.9.Miltenyi Biotec India Private Limited
  • 13.10.Norgen Biotek Corp.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14.Strategic Recommendations

15.About Us & Disclaimer